| ABEO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ABEO shares outstanding history going back to 10/24/2014:
Also see: ABEO Market Cap History ABEO YTD Return |
ABEO Shares Outstanding History — Abeona Therapeutics Share Count Over Time
As of 5/8/2026 Abeona Therapeutics has 57.00 million ABEO shares outstanding. Investors often track the ABEO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ABEO share count trends over time, with 49 historical shares outstanding datapoints presented, dating back to 10/24/2014.
| ABEO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABEO Historical Shares Outstanding: +98.09% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABEO Stock Price Chart |
| About Abeona Therapeutics Inc |
| Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in developing cell and gene therapies for life-threatening diseases. Co.'s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). Co.'s fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase III VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. We show 49 historical shares outstanding datapoints in our coverage of ABEO's shares outstanding history. Understanding the changing numbers of ABEO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABEO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research ABEO shares outstanding history as well as any other stock in our coverage universe. |
| ABEO Current Stock Quote |
Quotes delayed 20 minutes  Free ABEO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ABEO Share Performance |
| Shares Outstanding Peers |
| Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ABIO Shares Outstanding History ABMD Shares Outstanding History ABOS Shares Outstanding History ABSI Shares Outstanding History ABT Shares Outstanding History ABVC Shares Outstanding History ACAD Shares Outstanding History ACCD Shares Outstanding History ACER Shares Outstanding History ACET Shares Outstanding History More Healthcare companies » |
ABEO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
